Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04144166 · ClinicalTrials.gov registry record

Evaluation of Capillary Refill Index

A clinical trial, sponsored by Nihon Kohden.

Completed
Registry status
60
Enrollment target

NCT04144166: Completed study, sponsored by Nihon Kohden.

NCT04144166 is a clinical trial that has completed, run by Nihon Kohden. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04144166 has completed, sponsored by Nihon Kohden.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

Comparison of a peripheral perfusion assessment method using a pulse oximeter to the conventional capillary refill time visually assessed by a clinician.

Primary Outcome

The area under the curve (AUC) of the receiver operator characteristic (ROC) curve analysis on CRI values to predict probability of altered peripheral perfusion determined with the CRT test.

Interventions

  • DEVICE capillary refill index (CRI)

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-10-29
Est. Completion 2019-12-23
Nihon Kohden

14 total trials

What the finished NCT04144166 record still lists

NCT04144166 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which capillary refill index (CRI) is the first listed.

NCT04144166 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04144166 about?

NCT04144166 is a clinical study titled "Evaluation of Capillary Refill Index". Comparison of a peripheral perfusion assessment method using a pulse oximeter to the conventional capillary refill time visually assessed by a clinician.

What is the current status of trial NCT04144166?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2019-10-29. Estimated completion is 2019-12-23.

What interventions are being tested in trial NCT04144166?

The interventions under investigation include: capillary refill index (CRI) (DEVICE).

Who is sponsoring clinical trial NCT04144166?

This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04144166, the US trial registry maintained by the National Library of Medicine. NCT04144166 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.